Clinical Trial Update: Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating chloroquine for metabolic syndrome conditions has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hypertension
• Metabolic Syndrome
• Overweight
• Prediabetic State

Drugs mentioned

• Chloroquine (chloroquine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Metabolic Syndrome X, Overweight | Phase 2 | Status: COMPLETED | Results posted: 2022-05-10